US FDA clears Stryker’s Multigen 2 radiofrequency generator

69

Stryker has received US Food and Drug Administration 510(k) clearance for its MultiGen 2 radiofrequency (RF) generator. This product is designed to provide physicians with efficiency, control and reliability when performing radiofrequency ablation for the treatment of facet joint pain.

The MultiGen 2 RF Generator will debut at the Spine Intervention Society’s 25th annual meeting (SIS; July 19­–22, San Francisco, USA).

Using twice the industry standard for power, the MultiGen 2 Generator is intended to achieve target temperature quickly and with minimal errors, for increased reliability and efficiency. According to a press release, physicians can begin a procedure with the push of a button, create strip lesions without removing electrodes and resolve errors without stopping the. Procedures are customisable based on patient needs and physician preferences with flexible stimulation controls.

The MultiGen 2 RF generator makes up Stryker’s Performance platform with the Venom cannula and Electrode system.

LEAVE A REPLY